Literature DB >> 7899264

Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis.

J N van der Leij1, G H Visser, M T Bink-Boelkens, J F Meilof, C G Kallenberg.   

Abstract

In this short communication we describe a patient with anti-SSA and anti-SSB antibodies whose first child died of congenital complete heart block (CCHB). During her second pregnancy she was treated with prednisolone, azathioprine, and plasmapheresis, and levels of anti-SSA and anti-SSB antibodies fell significantly. The pregnancy evolved uneventfully and resulted in the birth of an unaffected male infant. This is the fourth reported case of a successful outcome of pregnancy after treatment with immunosuppressive drugs in a woman with a significant risk of recurrence of CCHB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899264     DOI: 10.1002/pd.1970141019

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.

Authors:  Renate Claus; Heiko Hickstein; Thomas Külz; Ute Lenschow; Doris Meiske; Andrea Kotitschke; Hans-Jürgen Thiesen; Peter Lorenz
Journal:  Rheumatol Int       Date:  2006-01-10       Impact factor: 2.631

Review 2.  Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus.

Authors:  Deborah M Friedman; Ann Rupel; Jill P Buyon
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

3.  Primary Sjogren's syndrome: a great masquerader.

Authors:  Naveen Kumar; Deepanjali Surendran; Bheemanathi Hanuman Srinivas; Chanaveerappa Bammigatti
Journal:  BMJ Case Rep       Date:  2019-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.